Systemic Therapy for Psoriasis

Cyclosporine (Neoral®)

Cyclosporine works by inhibiting T-lymphocyte transcription of IL-2. The long-term use of cyclosporine can be limited by the two major side effects of renal toxicity and hypertension (Grossman, Chevret, Abi-Rached, Blanchet, & Dubertret, 1996; Mrowietz et al., 1995; Lowe, Wieder, & Rosenbach, 1996; Powles et al., 1998). More recently it has been used in a short-term approach via intermittent 3 to 4 month intervals, either to obtain a quick response before transitioning to another agent, or to control a flare in a patient on stable systemic therapy (Finzi, 1996; Ho et al., 2001). Dosing is usually started at 4 to 5 mg/kg/d and then tapered as clearance is achieved.

Dermatology Nursing. 2008;20(2):105-111. © 2008  Jannetti Publications, Inc.

All other Dermatology Nursing Editorial Board members reported no actual or potential conflict of interest in relation to this continuing nursing education article.

Cite this: Systemic Therapy for Psoriasis - Medscape - Apr 01, 2008.